AD036

DRUG2 trials

Sponsors

Apnimed, Brigham and Women's Hospital

Conditions

Obstructive Sleep ApneaSleep Disordered Breathing

Phase 2

Crossover Trial of AD036 in Obstructive Sleep Apnea

CompletedNCT04445688

ApnimedObstructive Sleep Apnea

Start: 2020-07-15End: 2020-12-01Updated: 2023-09-14

Pharmacological Intervention for Symptomatic Mild Sleep Disordered Breathing

CompletedNCT04611750

Brigham and Women's HospitalSleep Disordered Breathing

Start: 2020-12-02End: 2022-01-18Updated: 2022-03-02

Related Papers

Night-to-night variability in obstructive sleep apnea severity, the physiological endotypes, and the frequency of flow limitation

SLEEP2024-12-174 citations

Efficacy of atomoxetine plus oxybutynin in the treatment of obstructive sleep apnea with moderate pharyngeal collapsibility

Sleep And Breathing2022-05-1336 citations